JANUVIA ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Sitagliptin. Full label: DailyMed.
JANUVIA ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Sitagliptin. Full label: DailyMed.
The recommended dose of JANUVIA is 100 mg once daily. JANUVIA can be taken with or without food. Dosage adjustment is recommended for patients with eGFR less than 45 mL/min/1.73 m 2.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema. History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Pancreatitis: There have been postmarketing reports of acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. If pancreatitis is suspected, promptly discontinue JANUVIA., Heart failure: Heart failure has been observed with two other members of the DPP-4 inhibitor class. Consider risks and benefits of JANUVIA in patients who have known risk factors for heart failure. Monitor patients for signs and symptoms., Acute Renal Failure: Has been reported postmarketing, sometimes requiring dialysis.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are also discussed elsewhere in the labeling: Pancreatitis, Heart Failure, Acute Renal Failure, Hypoglycemia with Concomitant Use with Insulin or Insulin Secretagogues, Hypersensitivity Reactions, Severe and Disabling Arthralgia, Bullous Pemphigoid Adverse reactions reported in ≥5% of patients treated with JANUVIA and more commonly than in patients treated with placebo are: upper respiratory…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
143 products from 69 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| ARROW 50MG Tablet | Sitagliptin (50MG) | Arrow pharmaceuticals pvt Ltd | |
| CITAZIP 100MG Tablet | Sitagliptin (100MG) | CTL Pharmaceuticals Pvt. Ltd. | |
| CITAZIP 25MG Tablet | Sitagliptin (25MG) | CTL Pharmaceuticals Pvt. Ltd. | |
| CITAZIP 50MG Tablet | Sitagliptin (50MG) | CTL Pharmaceuticals Pvt. Ltd. | |
| Glipsi 100 100mg Tablet | Sitagliptin (100mg) | National Healthcare Pvt. Ltd. | |
| Glipsi 50 50mg Tablet | Sitagliptin (50mg) | National Healthcare Pvt. Ltd. | |
| Gliptin 100mg Tablet | Sitagliptin (100mg) | Magnus Pharma Pvt. Ltd. | |
| Gliptin 50mg Tablet | Sitagliptin (50mg) | Magnus Pharma Pvt. Ltd. | |
| Insuglip 100 100mg Tablet | Sitagliptin (100mg) | S.R. Drug Laboratories Pvt. Ltd. | |
| Insuglip 50 50mg Tablet | Sitagliptin (50mg) | S.R. Drug Laboratories Pvt. Ltd. | |
| Istavel 100mg Tablet | Sitagliptin (100mg) | Sun Pharmaceutical Industries Ltd. | |
| Istavel 25mg Tablet | Sitagliptin (25mg) | Sun Pharmaceutical Industries Ltd. | |
| Istavel 50mg Tablet | Sitagliptin (50mg) | Sun Pharmaceutical Industries Ltd. | |
| Janvi 100 100mg Tablet | Sitagliptin (100mg) | Vijayadeep Laboratories Pvt. Ltd. | |
| Janvi 50 50mg Tablet | Sitagliptin (50mg) | Vijayadeep Laboratories Pvt. Ltd. | |
| Mysitag 100 100mg Tablet | Sitagliptin (100mg) | Sumy Pharmaceuticals Pvt. Ltd. | |
| Mysitag 25 25mg Tablet | Sitagliptin (25mg) | Sumy Pharmaceuticals Pvt. Ltd. | |
| Mysitag 50 50mg Tablet | Sitagliptin (50mg) | Sumy Pharmaceuticals Pvt. Ltd. | |
| Rolsiptin 100mg Tablet | Sitagliptin (100mg) | Royal Pharmaceuticals Pvt. Ltd | |
| Rolsiptin 50mg Tablet | Sitagliptin (50mg) | Royal Pharmaceuticals Pvt. Ltd | |
| S Glip 100 100mg Tablet | Sitagliptin (100mg) | Lomus Pharmaceutical Pvt. Ltd. | |
| S Glip 25 25mg Tablet | Sitagliptin (25mg) | Lomus Pharmaceutical Pvt. Ltd. | |
| S Glip 50 50mg Tablet | Sitagliptin (50mg) | Lomus Pharmaceutical Pvt. Ltd. | |
| Siglip 100 100mg Tablet | Sitagliptin (100mg) | Alive Pharmaceutical. Pvt. Ltd. | |
| Siglip 25 25mg Tablet | Sitagliptin (25mg) | Alive Pharmaceutical. Pvt. Ltd. | |
| Siglip 50 50mg Tablet | Sitagliptin (50mg) | Alive Pharmaceutical. Pvt. Ltd. | |
| Siptin 100 100mg Tablet | Sitagliptin (100mg) | Quest Pharmaceuticals Pvt. Ltd. | |
| Siptin 25 25mg Tablet | Sitagliptin (25mg) | Quest Pharmaceuticals Pvt. Ltd. | |
| Siptin 50 50mg Tablet | Sitagliptin (50mg) | Quest Pharmaceuticals Pvt. Ltd. | |
| Sitaglip 100 100mg Tablet | Sitagliptin (100mg) | Deurali Janta Pharmaceuticals Pvt. Ltd. |
Showing 30 of 143 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F).
Storage information from the U.S. FDA-approved label.
Sitagliptin is recorded in the NepalDoc medicine catalog for: Type 2 diabetes mellitus.
For Type 2 diabetes mellitus: Metformin + Glimepiride.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.